Alembic receives EIR for oncology injectable formulation facility at Panelav
This was a pre-approval inspection to cover our Oncology Injectable drug products for which ANDAs were filed with USFDA
This was a pre-approval inspection to cover our Oncology Injectable drug products for which ANDAs were filed with USFDA
The Institute will focus on increasing preparedness and laboratory capabilities for identification of novel and unknown zoonotic agents
Patients receiving Polivy plus R-CHP for DLBCL reported similar health-related quality of life outcomes
The plant, to be built in the Incheon Free Economic Zone in Songdo, Incheon, will be a facility for the manufacture of products such as sterile bags, cell culture media and membrane filters
GMP-compliant documentation of all manufacturing steps for cell and gene therapies
Asia’s premier and USA-patented, ANSSI Wellness for spinal decompression was launched in Pune
Results showed a statistically significant and clinically meaningful improvement in investigator-assessed progression-free survival
QS-21 in blockbuster Shingles vaccine, first vaccine approved for Malaria, promising RSV phase III candidate, and Covid-19 applications.
To fund the upfront payment, Biocon Biologics has secured USD 1.2 billion of Sustainability Linked Loan
Dapagliflozin reduces the risk of sustained eGFR, cardiovascular deaths and hospitalization for heart failure in adults with CKD
Subscribe To Our Newsletter & Stay Updated